View Financial HealthPolisan Holding 배당 및 자사주 매입배당 기준 점검 0/6Polisan Holding 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Mar 29Upcoming dividend of ₺0.40 per share at 3.4% yieldEligible shareholders must have bought the stock before 05 April 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 3.4%. Within top quartile of Turkish dividend payers (3.2%). Higher than average of industry peers (2.0%).Upcoming Dividend • Apr 05Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 12 April 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.7%). Lower than average of industry peers (0.8%).Upcoming Dividend • Mar 30Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 06 April 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.9%). Lower than average of industry peers (0.7%).Upcoming Dividend • Mar 30Upcoming dividend of ₺0.013 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 0.3%. Lower than top quartile of Turkish dividend payers (2.7%). Lower than average of industry peers (1.6%).모든 업데이트 보기Recent updatesReported Earnings • May 14First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₺1.38b (up 2.8% from 1Q 2025). Net loss: ₺336.1m (loss widened 93% from 1Q 2025).공시 • Apr 06Polisan Holding A.S., Annual General Meeting, Apr 30, 2026Polisan Holding A.S., Annual General Meeting, Apr 30, 2026. Location: dilovasi organize sanayi bolgesi, 1. kisim, liman caddesi, no:7, dilovasi, kocaeli TurkeyNew Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).Board Change • Apr 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Director Burcin Muftu was the last director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: ₺6.40b (up 3.4% from FY 2024). Net loss: ₺889.2m (loss widened 40% from FY 2024).Reported Earnings • Nov 12Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₺1.63b (down 1.2% from 3Q 2024). Net loss: ₺99.2m (loss narrowed 64% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 166 percentage points per year, which is a significant difference in performance.New Risk • Sep 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Turkish stocks, typically moving 91% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.New Risk • Jun 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₺2.91b (US$73.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₺2.91b market cap, or US$73.4m).Reported Earnings • May 14First quarter 2025 earnings released: ₺0.40 loss per share (vs ₺0.052 profit in 1Q 2024)First quarter 2025 results: ₺0.40 loss per share (down from ₺0.052 profit in 1Q 2024). Revenue: ₺1.45b (up 8.0% from 1Q 2024). Net loss: ₺306.0m (down ₺345.8m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (159% cash payout ratio). Share price has been volatile over the past 3 months (7.6% average weekly change).공시 • Mar 27Polisan Holding A.S., Annual General Meeting, Apr 28, 2025Polisan Holding A.S., Annual General Meeting, Apr 28, 2025. Location: dilovasi organize sanayi bolgesi, 1, kisim, liman caddesi, no:7, dilovasi, kocaeli TurkeyReported Earnings • Mar 09Full year 2024 earnings released: ₺0.83 loss per share (vs ₺0.99 profit in FY 2023)Full year 2024 results: ₺0.83 loss per share (down from ₺0.99 profit in FY 2023). Revenue: ₺6.19b (up 11% from FY 2023). Net loss: ₺633.3m (down 185% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₺11.94, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 285% over the past three years.Reported Earnings • Nov 10Third quarter 2024 earnings released: ₺0.36 loss per share (vs ₺0.40 profit in 3Q 2023)Third quarter 2024 results: ₺0.36 loss per share (down from ₺0.40 profit in 3Q 2023). Revenue: ₺1.65b (up 23% from 3Q 2023). Net loss: ₺276.2m (down 190% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.공시 • Sep 23Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)Reported Earnings • Sep 06Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: ₺1.30b (up 14% from 2Q 2023). Net loss: ₺156.6m (down 270% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.공시 • Aug 22Polisan Holding A.S. to Report Q2, 2024 Results on Sep 05, 2024Polisan Holding A.S. announced that they will report Q2, 2024 results on Sep 05, 2024Reported Earnings • Jun 05First quarter 2024 earnings released: EPS: ₺0.25 (vs ₺0.016 in 1Q 2023)First quarter 2024 results: EPS: ₺0.25 (up from ₺0.016 in 1Q 2023). Revenue: ₺1.24b (up 20% from 1Q 2023). Net income: ₺186.6m (up ₺174.8m from 1Q 2023). Profit margin: 15% (up from 1.1% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has increased by 66% per year, which means it is tracking significantly ahead of earnings growth.공시 • May 22Polisan Holding A.S. to Report Q1, 2024 Results on Jun 03, 2024Polisan Holding A.S. announced that they will report Q1, 2024 results at 5:30 PM, GTB Standard Time on Jun 03, 2024Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 3 highly experienced directors. CEO & Executive Director Mehmet Hacikamiloglu was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Apr 02Full year 2023 earnings released: EPS: ₺0.99 (vs ₺2.15 in FY 2022)Full year 2023 results: EPS: ₺0.99 (down from ₺2.15 in FY 2022). Revenue: ₺5.60b (up 34% from FY 2022). Net income: ₺747.7m (down 54% from FY 2022). Profit margin: 13% (down from 39% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 70% per year whereas the company’s share price has increased by 67% per year.Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₺15.32, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 23x in the Chemicals industry in Turkey. Total returns to shareholders of 388% over the past three years.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₺11.30, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 190% over the past three years.New Risk • Nov 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (10% average weekly change).Valuation Update With 7 Day Price Move • Nov 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₺16.08, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 21x in the Chemicals industry in Turkey. Total returns to shareholders of 330% over the past three years.Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: ₺0.40 (vs ₺0.17 in 3Q 2022)Third quarter 2023 results: EPS: ₺0.40 (up from ₺0.17 in 3Q 2022). Revenue: ₺1.34b (up 11% from 3Q 2022). Net income: ₺305.9m (up 133% from 3Q 2022). Profit margin: 23% (up from 11% in 3Q 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺12.58, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 22x in the Chemicals industry in Turkey. Total returns to shareholders of 221% over the past three years.Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₺17.93, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 20x in the Chemicals industry in Turkey. Total returns to shareholders of 542% over the past three years.Reported Earnings • Aug 06Second quarter 2023 earnings released: EPS: ₺0.12 (vs ₺0.24 in 2Q 2022)Second quarter 2023 results: EPS: ₺0.12 (down from ₺0.24 in 2Q 2022). Revenue: ₺1.14b (flat on 2Q 2022). Net income: ₺92.1m (down 50% from 2Q 2022). Profit margin: 8.1% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 31Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₺8.63, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 208% over the past three years.Reported Earnings • May 07First quarter 2023 earnings released: EPS: ₺0.016 (vs ₺0.17 in 1Q 2022)First quarter 2023 results: EPS: ₺0.016 (down from ₺0.17 in 1Q 2022). Revenue: ₺1.03b (up 25% from 1Q 2022). Net income: ₺11.8m (down 91% from 1Q 2022). Profit margin: 1.1% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺9.53, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 10x in the Chemicals industry in Turkey. Total returns to shareholders of 310% over the past three years.Upcoming Dividend • Mar 29Upcoming dividend of ₺0.40 per share at 3.4% yieldEligible shareholders must have bought the stock before 05 April 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 3.4%. Within top quartile of Turkish dividend payers (3.2%). Higher than average of industry peers (2.0%).Reported Earnings • Mar 03Full year 2022 earnings released: EPS: ₺2.15 (vs ₺0.37 in FY 2021)Full year 2022 results: EPS: ₺2.15 (up from ₺0.37 in FY 2021). Revenue: ₺4.20b (up 113% from FY 2021). Net income: ₺1.63b (up 483% from FY 2021). Profit margin: 39% (up from 14% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 61% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₺9.27, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 222% over the past three years.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₺8.59, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 13x in the Chemicals industry in Turkey. Total returns to shareholders of 159% over the past three years.Valuation Update With 7 Day Price Move • Jan 05Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺11.66, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.Reported Earnings • Nov 02Third quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.06 in 3Q 2021)Third quarter 2022 results: EPS: ₺0.17 (up from ₺0.06 in 3Q 2021). Revenue: ₺1.22b (up 136% from 3Q 2021). Net income: ₺131.2m (up 190% from 3Q 2021). Profit margin: 11% (up from 8.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₺9.81, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺7.71, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 178% over the past three years.Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₺6.79, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 213% over the past three years.Reported Earnings • Aug 10Second quarter 2022 earnings released: EPS: ₺0.24 (vs ₺0.054 in 2Q 2021)Second quarter 2022 results: EPS: ₺0.24 (up from ₺0.054 in 2Q 2021). Revenue: ₺1.14b (up 164% from 2Q 2021). Net income: ₺185.8m (up 355% from 2Q 2021). Profit margin: 16% (up from 9.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺5.65, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 15x in the Chemicals industry in Turkey. Total returns to shareholders of 156% over the past three years.Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺4.47, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 115% over the past three years.Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₺3.63, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 17% over the past three years.Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.051 in 1Q 2021)First quarter 2022 results: EPS: ₺0.17 (up from ₺0.051 in 1Q 2021). Revenue: ₺826.1m (up 133% from 1Q 2021). Net income: ₺131.2m (up 238% from 1Q 2021). Profit margin: 16% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Esra Yazici was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Apr 05Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 12 April 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.7%). Lower than average of industry peers (0.8%).Upcoming Dividend • Mar 30Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 06 April 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.9%). Lower than average of industry peers (0.7%).Reported Earnings • Mar 09Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₺0.37 (up from ₺0.17 in FY 2020). Revenue: ₺1.97b (up 87% from FY 2020). Net income: ₺279.9m (up 121% from FY 2020). Profit margin: 14% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 05Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₺515.2m (up 81% from 3Q 2020). Net income: ₺45.2m (up 168% from 3Q 2020). Profit margin: 8.8% (up from 5.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS ₺0.054 (vs ₺0.029 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₺431.1m (up 85% from 2Q 2020). Net income: ₺40.8m (up 85% from 2Q 2020). Profit margin: 9.5% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Upcoming Dividend • Mar 30Upcoming dividend of ₺0.013 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 0.3%. Lower than top quartile of Turkish dividend payers (2.7%). Lower than average of industry peers (1.6%).Valuation Update With 7 Day Price Move • Mar 22Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺3.19, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 35x in the Chemicals industry in Turkey. Total returns to shareholders of 4.1% over the past three years.Reported Earnings • Mar 12Full year 2020 earnings released: EPS ₺0.17 (vs ₺0.086 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₺1.05b (up 3.8% from FY 2019). Net income: ₺126.6m (up 94% from FY 2019). Profit margin: 12% (up from 6.4% in FY 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.Is New 90 Day High Low • Feb 24New 90-day low: ₺3.65The company is down 7.0% from its price of ₺3.92 on 26 November 2020. The Turkish market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 65% over the same period.Is New 90 Day High Low • Jan 25New 90-day high: ₺4.32The company is up 17% from its price of ₺3.70 on 27 October 2020. The Turkish market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 64% over the same period.Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of ₺72.2m, up 64% from the prior year. Total revenue was ₺990.2m over the last 12 months, down 11% from the prior year.Is New 90 Day High Low • Oct 05New 90-day high: ₺3.38The company is up 3.0% from its price of ₺3.28 on 07 July 2020. The Turkish market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 POLHO 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: POLHO 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Polisan Holding 배당 수익률 vs 시장POLHO의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (POLHO)0%시장 하위 25% (TR)0.5%시장 상위 25% (TR)3.1%업계 평균 (Chemicals)1.1%분석가 예측 (POLHO) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 POLHO 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 POLHO 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: POLHO TR 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: POLHO 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YTR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/02 19:09종가2026/07/02 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Polisan Holding A.S.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kenan TuranYatirim Finansman Menkul Degerler A.S.
Upcoming Dividend • Mar 29Upcoming dividend of ₺0.40 per share at 3.4% yieldEligible shareholders must have bought the stock before 05 April 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 3.4%. Within top quartile of Turkish dividend payers (3.2%). Higher than average of industry peers (2.0%).
Upcoming Dividend • Apr 05Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 12 April 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.7%). Lower than average of industry peers (0.8%).
Upcoming Dividend • Mar 30Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 06 April 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.9%). Lower than average of industry peers (0.7%).
Upcoming Dividend • Mar 30Upcoming dividend of ₺0.013 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 0.3%. Lower than top quartile of Turkish dividend payers (2.7%). Lower than average of industry peers (1.6%).
Reported Earnings • May 14First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₺1.38b (up 2.8% from 1Q 2025). Net loss: ₺336.1m (loss widened 93% from 1Q 2025).
공시 • Apr 06Polisan Holding A.S., Annual General Meeting, Apr 30, 2026Polisan Holding A.S., Annual General Meeting, Apr 30, 2026. Location: dilovasi organize sanayi bolgesi, 1. kisim, liman caddesi, no:7, dilovasi, kocaeli Turkey
New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).
Board Change • Apr 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Director Burcin Muftu was the last director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 12Full year 2025 earnings releasedFull year 2025 results: Revenue: ₺6.40b (up 3.4% from FY 2024). Net loss: ₺889.2m (loss widened 40% from FY 2024).
Reported Earnings • Nov 12Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₺1.63b (down 1.2% from 3Q 2024). Net loss: ₺99.2m (loss narrowed 64% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 166 percentage points per year, which is a significant difference in performance.
New Risk • Sep 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Turkish stocks, typically moving 91% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company.
New Risk • Jun 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₺2.91b (US$73.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₺2.91b market cap, or US$73.4m).
Reported Earnings • May 14First quarter 2025 earnings released: ₺0.40 loss per share (vs ₺0.052 profit in 1Q 2024)First quarter 2025 results: ₺0.40 loss per share (down from ₺0.052 profit in 1Q 2024). Revenue: ₺1.45b (up 8.0% from 1Q 2024). Net loss: ₺306.0m (down ₺345.8m from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.
New Risk • Apr 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (159% cash payout ratio). Share price has been volatile over the past 3 months (7.6% average weekly change).
공시 • Mar 27Polisan Holding A.S., Annual General Meeting, Apr 28, 2025Polisan Holding A.S., Annual General Meeting, Apr 28, 2025. Location: dilovasi organize sanayi bolgesi, 1, kisim, liman caddesi, no:7, dilovasi, kocaeli Turkey
Reported Earnings • Mar 09Full year 2024 earnings released: ₺0.83 loss per share (vs ₺0.99 profit in FY 2023)Full year 2024 results: ₺0.83 loss per share (down from ₺0.99 profit in FY 2023). Revenue: ₺6.19b (up 11% from FY 2023). Net loss: ₺633.3m (down 185% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₺11.94, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 285% over the past three years.
Reported Earnings • Nov 10Third quarter 2024 earnings released: ₺0.36 loss per share (vs ₺0.40 profit in 3Q 2023)Third quarter 2024 results: ₺0.36 loss per share (down from ₺0.40 profit in 3Q 2023). Revenue: ₺1.65b (up 23% from 3Q 2023). Net loss: ₺276.2m (down 190% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Sep 23Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)Polisan Holding A.S.(IBSE:POLHO) dropped from FTSE All-World Index (USD)
Reported Earnings • Sep 06Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: ₺1.30b (up 14% from 2Q 2023). Net loss: ₺156.6m (down 270% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Aug 22Polisan Holding A.S. to Report Q2, 2024 Results on Sep 05, 2024Polisan Holding A.S. announced that they will report Q2, 2024 results on Sep 05, 2024
Reported Earnings • Jun 05First quarter 2024 earnings released: EPS: ₺0.25 (vs ₺0.016 in 1Q 2023)First quarter 2024 results: EPS: ₺0.25 (up from ₺0.016 in 1Q 2023). Revenue: ₺1.24b (up 20% from 1Q 2023). Net income: ₺186.6m (up ₺174.8m from 1Q 2023). Profit margin: 15% (up from 1.1% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has increased by 66% per year, which means it is tracking significantly ahead of earnings growth.
공시 • May 22Polisan Holding A.S. to Report Q1, 2024 Results on Jun 03, 2024Polisan Holding A.S. announced that they will report Q1, 2024 results at 5:30 PM, GTB Standard Time on Jun 03, 2024
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 3 highly experienced directors. CEO & Executive Director Mehmet Hacikamiloglu was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Apr 02Full year 2023 earnings released: EPS: ₺0.99 (vs ₺2.15 in FY 2022)Full year 2023 results: EPS: ₺0.99 (down from ₺2.15 in FY 2022). Revenue: ₺5.60b (up 34% from FY 2022). Net income: ₺747.7m (down 54% from FY 2022). Profit margin: 13% (down from 39% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 70% per year whereas the company’s share price has increased by 67% per year.
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₺15.32, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 23x in the Chemicals industry in Turkey. Total returns to shareholders of 388% over the past three years.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₺11.30, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 19x in the Chemicals industry in Turkey. Total returns to shareholders of 190% over the past three years.
New Risk • Nov 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Turkish stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (10% average weekly change).
Valuation Update With 7 Day Price Move • Nov 21Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₺16.08, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 21x in the Chemicals industry in Turkey. Total returns to shareholders of 330% over the past three years.
Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: ₺0.40 (vs ₺0.17 in 3Q 2022)Third quarter 2023 results: EPS: ₺0.40 (up from ₺0.17 in 3Q 2022). Revenue: ₺1.34b (up 11% from 3Q 2022). Net income: ₺305.9m (up 133% from 3Q 2022). Profit margin: 23% (up from 11% in 3Q 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺12.58, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 22x in the Chemicals industry in Turkey. Total returns to shareholders of 221% over the past three years.
Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improves as stock rises 36%After last week's 36% share price gain to ₺17.93, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 20x in the Chemicals industry in Turkey. Total returns to shareholders of 542% over the past three years.
Reported Earnings • Aug 06Second quarter 2023 earnings released: EPS: ₺0.12 (vs ₺0.24 in 2Q 2022)Second quarter 2023 results: EPS: ₺0.12 (down from ₺0.24 in 2Q 2022). Revenue: ₺1.14b (flat on 2Q 2022). Net income: ₺92.1m (down 50% from 2Q 2022). Profit margin: 8.1% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 58% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 31Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₺8.63, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 208% over the past three years.
Reported Earnings • May 07First quarter 2023 earnings released: EPS: ₺0.016 (vs ₺0.17 in 1Q 2022)First quarter 2023 results: EPS: ₺0.016 (down from ₺0.17 in 1Q 2022). Revenue: ₺1.03b (up 25% from 1Q 2022). Net income: ₺11.8m (down 91% from 1Q 2022). Profit margin: 1.1% (down from 16% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 55% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₺9.53, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 10x in the Chemicals industry in Turkey. Total returns to shareholders of 310% over the past three years.
Upcoming Dividend • Mar 29Upcoming dividend of ₺0.40 per share at 3.4% yieldEligible shareholders must have bought the stock before 05 April 2023. Payment date: 07 April 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 3.4%. Within top quartile of Turkish dividend payers (3.2%). Higher than average of industry peers (2.0%).
Reported Earnings • Mar 03Full year 2022 earnings released: EPS: ₺2.15 (vs ₺0.37 in FY 2021)Full year 2022 results: EPS: ₺2.15 (up from ₺0.37 in FY 2021). Revenue: ₺4.20b (up 113% from FY 2021). Net income: ₺1.63b (up 483% from FY 2021). Profit margin: 39% (up from 14% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 61% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₺9.27, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 222% over the past three years.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₺8.59, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 13x in the Chemicals industry in Turkey. Total returns to shareholders of 159% over the past three years.
Valuation Update With 7 Day Price Move • Jan 05Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺11.66, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.
Reported Earnings • Nov 02Third quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.06 in 3Q 2021)Third quarter 2022 results: EPS: ₺0.17 (up from ₺0.06 in 3Q 2021). Revenue: ₺1.22b (up 136% from 3Q 2021). Net income: ₺131.2m (up 190% from 3Q 2021). Profit margin: 11% (up from 8.8% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₺9.81, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 290% over the past three years.
Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺7.71, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 11x in the Chemicals industry in Turkey. Total returns to shareholders of 178% over the past three years.
Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₺6.79, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 213% over the past three years.
Reported Earnings • Aug 10Second quarter 2022 earnings released: EPS: ₺0.24 (vs ₺0.054 in 2Q 2021)Second quarter 2022 results: EPS: ₺0.24 (up from ₺0.054 in 2Q 2021). Revenue: ₺1.14b (up 164% from 2Q 2021). Net income: ₺185.8m (up 355% from 2Q 2021). Profit margin: 16% (up from 9.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺5.65, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 15x in the Chemicals industry in Turkey. Total returns to shareholders of 156% over the past three years.
Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₺4.47, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 14x in the Chemicals industry in Turkey. Total returns to shareholders of 115% over the past three years.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₺3.63, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 16x in the Chemicals industry in Turkey. Total returns to shareholders of 17% over the past three years.
Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: ₺0.17 (vs ₺0.051 in 1Q 2021)First quarter 2022 results: EPS: ₺0.17 (up from ₺0.051 in 1Q 2021). Revenue: ₺826.1m (up 133% from 1Q 2021). Net income: ₺131.2m (up 238% from 1Q 2021). Profit margin: 16% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Esra Yazici was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Apr 05Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 12 April 2022. Payment date: 14 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.7%). Lower than average of industry peers (0.8%).
Upcoming Dividend • Mar 30Upcoming dividend of ₺0.02 per shareEligible shareholders must have bought the stock before 06 April 2022. Payment date: 08 April 2022. Payout ratio is a comfortable 3.6% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Turkish dividend payers (3.9%). Lower than average of industry peers (0.7%).
Reported Earnings • Mar 09Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₺0.37 (up from ₺0.17 in FY 2020). Revenue: ₺1.97b (up 87% from FY 2020). Net income: ₺279.9m (up 121% from FY 2020). Profit margin: 14% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 05Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₺515.2m (up 81% from 3Q 2020). Net income: ₺45.2m (up 168% from 3Q 2020). Profit margin: 8.8% (up from 5.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS ₺0.054 (vs ₺0.029 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₺431.1m (up 85% from 2Q 2020). Net income: ₺40.8m (up 85% from 2Q 2020). Profit margin: 9.5% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Mar 30Upcoming dividend of ₺0.013 per shareEligible shareholders must have bought the stock before 06 April 2021. Payment date: 08 April 2021. Trailing yield: 0.3%. Lower than top quartile of Turkish dividend payers (2.7%). Lower than average of industry peers (1.6%).
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₺3.19, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 35x in the Chemicals industry in Turkey. Total returns to shareholders of 4.1% over the past three years.
Reported Earnings • Mar 12Full year 2020 earnings released: EPS ₺0.17 (vs ₺0.086 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₺1.05b (up 3.8% from FY 2019). Net income: ₺126.6m (up 94% from FY 2019). Profit margin: 12% (up from 6.4% in FY 2019). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.
Is New 90 Day High Low • Feb 24New 90-day low: ₺3.65The company is down 7.0% from its price of ₺3.92 on 26 November 2020. The Turkish market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 65% over the same period.
Is New 90 Day High Low • Jan 25New 90-day high: ₺4.32The company is up 17% from its price of ₺3.70 on 27 October 2020. The Turkish market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 64% over the same period.
Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of ₺72.2m, up 64% from the prior year. Total revenue was ₺990.2m over the last 12 months, down 11% from the prior year.
Is New 90 Day High Low • Oct 05New 90-day high: ₺3.38The company is up 3.0% from its price of ₺3.28 on 07 July 2020. The Turkish market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.